Session Details
[27-58-am]Pharmaceutics 4, ADME/PK-PD/Others
Fri. Mar 27, 2026 9:30 AM - 11:30 AM JST
Fri. Mar 27, 2026 12:30 AM - 2:30 AM UTC
Fri. Mar 27, 2026 12:30 AM - 2:30 AM UTC
Room 58 (C206, Bldg. 2, Area 2 [2F])
Discusser: Makiya Nishikawa, Yuma Yamada
[27-58-am-01]Pharmacokinetic evaluation of fixed-dose combination of ibuprofen and acetaminophen in over-the-counter drugs
○Ichiro Kawase1, Mitsuaki Chujo1, Nobuo Miyadai1, Satoko Ueda1, So Young Ryu1 (1. SSP co. ltd.)
[27-58-am-02]Development of in vitro BBB model using human iPS cells-derived cells
○Tomoko YAMAGUCHI1, Misae NISHIJIMA1, Kenji KAWABATA1,2 (1. NIBN, 2. Grad. Sch. Pharm. Sci., Osaka Univ.)
[27-58-am-03]Time-dependent inhibition of CYP2D6 by levomepromazine
○Yasuhiro Masubuchi1, Chinami Iijima1 (1. Chiba Inst. Sci.)
[27-58-am-04]Inhibitory Effect of Miquelianin on CDDP-Induced Renal Tubular Epithelial Cell Death
Kou Nakatani1, Megu Kikuta1, Shiho Inoue1, ○Mitsuru Hashimoto1 (1. Col. Pharm. Sci., Matsuyama Univ.)
[27-58-am-05]Hemin attenuates amiodarone-induced cytotoxicity independently of HO-1 induction
○Takafumi Nakano1, Maho Takahashi1, Eiri Yamaoka1, Takashi Mizuma1 (1. Fac. Pharm. Sci., Teikyo Heisei Univ.)
[27-58-am-06]The inhibitory effect of dexamethasone on changes in the pharmacokinetics of cefoperazone induced by LPS treatment
○Ayano Hibi1, Miki Katoh1, Masayuki Nadai1 (1. Meijo Univ.)
[27-58-am-07]The role of PTGS1 in multidrug resistance in chronic myelogenous leukemia cell line K562/ADM
○Yoshihiko Shibayama1 (1. Health Sciences University of Hokkaido)
[27-58-am-08]Regulation of UGT1A6 expression by β-catenin-mediated signaling in cancer cells
○Miki Katoh1, Masayuki Nadai1 (1. Meijo Univ.)